Stopping use of jabs brings regained weight plus loss of benefits regarding ‘bad’ cholesterol and blood pressure
People who stop using the weight-loss jab Mounjaro not only tend to regain weight, but experience a reversal in other health improvements too, research suggests.
Mounjaro, which contains the active ingredient tirzepatide, has become a popular medication for weight loss, with studies suggesting that it can help people lose an average of 20% of their body weight after 72 weeks of treatment.
However, research has previously found that people who stop using tirzepatide tend to regain much of the weight they have lost.
Now experts studying results from a clinical trial known as Surmount-4 say other benefits seen with the medication, such as reduced blood pressure and lower levels of “bad” cholesterol, also go into reverse upon stopping the jabs.
